Diferencia entre revisiones de «Template:CHA2DS2VASc Calculator»
(Create CHA2DS2-VASc calculator template for atrial fibrillation stroke risk) |
(Add wikilinks: anticoagulation) |
||
| (No se muestran 4 ediciones intermedias del mismo usuario) | |||
| Línea 5: | Línea 5: | ||
[[Category:Calculator templates]] | [[Category:Calculator templates]] | ||
</noinclude> | </noinclude>=== CHA₂DS₂-VASc Score === | ||
<div class="calculator-container" data-calculator-refresh-on-load="true"> | |||
{| class="wikitable" style="width:100%; border-collapse:collapse;" | {| class="wikitable" style="width:100%; border-collapse:collapse;" | ||
|+ style="font-size:16px; font-weight:bold; padding:8px; background:#4a90d9; color:white;" | CHA₂DS₂-VASc Score Calculator | |+ style="font-size:16px; font-weight:bold; padding:8px; background:#4a90d9; color:white;" | CHA₂DS₂-VASc Score Calculator | ||
| Línea 14: | Línea 15: | ||
|- | |- | ||
| '''C'''ongestive heart failure (or LVEF ≤40%) | | '''C'''ongestive heart failure (or LVEF ≤40%) | ||
| | | {{calculator|id=cv_chfNo|type=radio|name=cv_chf|default=1}} | ||
| | | {{calculator|id=cv_chfYes|type=radio|name=cv_chf}} (+1) | ||
|- | |- | ||
| '''H'''ypertension | | '''H'''ypertension | ||
| | | {{calculator|id=cv_htnNo|type=radio|name=cv_htn|default=1}} | ||
| | | {{calculator|id=cv_htnYes|type=radio|name=cv_htn}} (+1) | ||
|- | |- | ||
| '''A'''ge ≥75 years | | '''A'''ge ≥75 years | ||
| | | {{calculator|id=cv_a75No|type=radio|name=cv_a75|default=1}} | ||
| | | {{calculator|id=cv_a75Yes|type=radio|name=cv_a75}} (+2) | ||
|- | |- | ||
| '''D'''iabetes mellitus | | '''D'''iabetes mellitus | ||
| | | {{calculator|id=cv_dmNo|type=radio|name=cv_dm|default=1}} | ||
| | | {{calculator|id=cv_dmYes|type=radio|name=cv_dm}} (+1) | ||
|- | |- | ||
| '''S'''troke/TIA/thromboembolism | | '''S'''troke/TIA/thromboembolism | ||
| | | {{calculator|id=cv_strNo|type=radio|name=cv_str|default=1}} | ||
| | | {{calculator|id=cv_strYes|type=radio|name=cv_str}} (+2) | ||
|- | |- | ||
| '''V'''ascular disease (prior MI, PAD, aortic plaque) | | '''V'''ascular disease (prior MI, PAD, aortic plaque) | ||
| | | {{calculator|id=cv_vasNo|type=radio|name=cv_vas|default=1}} | ||
| | | {{calculator|id=cv_vasYes|type=radio|name=cv_vas}} (+1) | ||
|- | |- | ||
| '''A'''ge 65–74 years | | '''A'''ge 65–74 years | ||
| | | {{calculator|id=cv_a65No|type=radio|name=cv_a65|default=1}} | ||
| | | {{calculator|id=cv_a65Yes|type=radio|name=cv_a65}} (+1) | ||
|- | |- | ||
| '''S'''ex category (female) | | '''S'''ex category (female) | ||
| | | {{calculator|id=cv_sexNo|type=radio|name=cv_sex|default=1}} | ||
| | | {{calculator|id=cv_sexYes|type=radio|name=cv_sex}} (+1) | ||
|- | |- | ||
! style="background:#4a90d9; color:white;" | CHA₂DS₂-VASc Score | ! style="background:#4a90d9; color:white;" | CHA₂DS₂-VASc Score | ||
! colspan="2" style="background:#4a90d9; color:white;" | | ! colspan="2" style="background:#4a90d9; color:white;" | {{calculator|id=cv_total|type=plain|formula=cv_chfYes+cv_htnYes+cv_a75Yes*2+cv_dmYes+cv_strYes*2+cv_vasYes+cv_a65Yes+cv_sexYes|style=min-width:3ch;display:inline-block}} / 9 | ||
|} | |} | ||
| Línea 57: | Línea 58: | ||
|- | |- | ||
| style="background:#f39c12; color:white; text-align:center; font-weight:bold;" | 1 | | style="background:#f39c12; color:white; text-align:center; font-weight:bold;" | 1 | ||
| '''Low-Moderate Risk''' — 0.6% annual stroke risk (males). Consider anticoagulation (esp. if not due to female sex alone). | | '''Low-Moderate Risk''' — 0.6% annual stroke risk (males). Consider [[Anticoagulation|anticoagulation]] (esp. if not due to female sex alone). | ||
|- | |- | ||
| style="background:#e74c3c; color:white; text-align:center; font-weight:bold;" | ≥2 | | style="background:#e74c3c; color:white; text-align:center; font-weight:bold;" | ≥2 | ||
| '''Moderate-High Risk''' — ≥2.2% annual stroke risk. Oral anticoagulation recommended. | | '''Moderate-High Risk''' — ≥2.2% annual stroke risk. Oral anticoagulation recommended. | ||
|} | |} | ||
</div | |||
{| class="wikitable" style="width:100%; margin-top:4px; font-size:90%;" | |||
! References | |||
|- | |||
| | |||
* Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. ''Chest.'' 2010;137(2):263-272. PMID 19762550. | |||
* January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 Guideline for Management of Patients With Atrial Fibrillation. ''J Am Coll Cardiol.'' 2019;74(1):104-132. PMID 30703431. | |||
|} | |||
</div> | |||
Revisión actual - 16:49 21 mar 2026
Interactive CHA₂DS₂-VASc Score calculator for atrial fibrillation stroke risk. Requires the calculator gadget.
Usage: {{CHA2DS2VASc Calculator}}
CHA₂DS₂-VASc Score
| Criteria | No (0) | Yes |
|---|---|---|
| Congestive heart failure (or LVEF ≤40%) | 1 | (+1) |
| Hypertension | 1 | (+1) |
| Age ≥75 years | 1 | (+2) |
| Diabetes mellitus | 1 | (+1) |
| Stroke/TIA/thromboembolism | 1 | (+2) |
| Vascular disease (prior MI, PAD, aortic plaque) | 1 | (+1) |
| Age 65–74 years | 1 | (+1) |
| Sex category (female) | 1 | (+1) |
| CHA₂DS₂-VASc Score | / 9 | |
| Interpretation | |
|---|---|
| 0 | Low Risk — 0.2% annual stroke risk (males). Anticoagulation generally not recommended. |
| 1 | Low-Moderate Risk — 0.6% annual stroke risk (males). Consider anticoagulation (esp. if not due to female sex alone). |
| ≥2 | Moderate-High Risk — ≥2.2% annual stroke risk. Oral anticoagulation recommended. |
| References |
|---|
|